Coqui Radio Pharmaceuticals

Providing The world with outstanding health related products.

Catalyst Pharmaceutical Partners is a specialty pharmaceutical company that is focused on the development and commercialization of prescription drugs for the treatment of addiction. The company undertakes research and development activities in the area of developing the molecule vigabatrin, which is used in the treatment for addiction to cocaine, amphetamines and other addictive substances. Its product candidate based on vigabatrin is CPP-109, which has been granted fast-track status by the Food and Drug Administration for the treatment of cocaine addiction. The company has an on-site laboratory and a staff of trained professionals. It has also conducted human clinical trials of CPP-109. The company is located in Coral Gables, Fla.

Noven Pharmaceuticals core business resides in transdermal drug delivery. As a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products, the company s prescription patches are sold in more than 30 countries. Together with Novartis Pharmaceuticals Corporation, the company owns Novogyne Pharmaceuticals, a women s health products company. Among other products, Novogyne markets and sells Noven s Vivelle-Dot product, one of the smallest estrogen patches in the world and one of the most dispensed estrogen patches in the United States. Noven is committed to expanding available transdermal therapies for the benefit of patients, partners and shareholders. Noven Pharmaceuticals is headquartered in Miami.